title: [Difficulties in treatment of kidney diseases related to HCV infection].
abstract: Membranoproliferative glomerulonephritis is a typical manifestation of HCV infection, in most cases connected with cryoglobulinemia. Efficiacy of antiviral treatment with interferon and ribavirine in this group of patients is lower compared to the population without kidney disease. Another options of treatment are: use of rituximab (monoclonal antibody destroying lymphocytes B), low-antigen containing diet, plasmapheresis and immunosupressive treatment. Recommendations of antiviral treatment in HCV-infected patients with concomitant renal failure were presented.
authors.affiliation: Klinika Hepatologii i Nabytych Niedoborów Immunologicznych Warszawskiego Uniwersytetu Medycznego.
authors.forename: Joanna
authors.initials: J
authors.lastname: Jabłońska
authors.forename: Joanna
authors.initials: J
authors.lastname: Kozłowska
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D003449:Cryoglobulinemia / Q000821:virology; D004035:Diet Therapy / Q000379:methods; D015432:Glomerulonephritis, Membranoproliferative / Q000175:diagnosis / Q000178:diet therapy / Q000188:drug therapy / Q000628:therapy* / Q000821:virology*; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin